Next day delivery
Discreet & confidential
UK licensed medication
Mounjaro contains Tirzapetide as an active ingredient, it is a first-in-class medicine that activates both the GLP-1 and...
Mounjaro contains Tirzapetide as an active ingredient, it is a first-in-class medicine that activates both the GLP-1 and GIP receptors, which leads to improved blood sugar control.
This medication has garnered significant attention for its effectiveness in both controlling type 2 diabetes and aiding in weight management. Clinical studies have shown remarkable results, with obese and overweight individuals experiencing significant weight reductions of around 20-25% over a year when compared to placebo treatments.
Mounjaro operates by enhancing the feeling of fullness, which naturally reduces food intake. Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are hormones involved in blood sugar control. The combination of GIP and GLP-1 also slows gastric emptying, thereby reducing appetite and making you feel fuller for longer.
Mounjaro is administered as a subcutaneous injection (under the skin) ONCE weekly. It comes in 6 different strengths, where the dose is adjusted by the prescriber as tolerated by an individual to meet blood sugar goals.